logo
From Misdiagnosis to Mission: How One Man's Ordeal Became a Blueprint for Perseverance

From Misdiagnosis to Mission: How One Man's Ordeal Became a Blueprint for Perseverance

Entrepreneur4 days ago
What followed was not just a lapse in judgment; it was a decades-long system failure. Dean became the unseen patient. The ignored anomaly. No one had time to read the story. But like any great founder building something against the odds, he—and his tenacious family—refused to give up.
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
When Dean Gregorie first developed a small hump below his neck at age sixteen, few paid it any mind. His mother, though, saw more. Weight gain. The round face. The bone-deep fatigue. To her, it spelled something far more complex: Cushing's disease. But when she voiced her concerns, doctors smiled politely and waved them off.
"Teenagers gain weight," they said.
What followed was not just a lapse in judgment; it was a decades-long system failure. Dean became the unseen patient. The ignored anomaly. No one had time to read the story. But like any great founder building something against the odds, he—and his tenacious family—refused to give up.
Seeing What Others Miss
The early symptoms were dismissed with lazy diagnoses: poor diet, lack of exercise, and normal adolescence. But Helen Gregorie was relentless. She scoured medical journals. Dug through case studies. Her instincts shouted, "Cushing's." But doctors, operating within conventional playbooks, refused to explore a rare diagnosis. In startup parlance, they ignored the outlier data, clinging to averages instead of curiosity.
Dean was a patient who was overlooked not because of ambiguity, but because of predictability. If he had been a product, he would've been shut down in beta without anyone reading the specs.
The Burn Cost of Delay
Over the next two decades, Dean cycled through over fifty medical professionals. His symptoms worsened: purple striations, skyrocketing blood pressure, relentless fatigue. And yet the narrative never changed. "Lifestyle," they told him.
Imagine pitching the same idea to dozens of venture capitalists, each one dismissing it for a reason you know isn't true. Dean wasn't lazy or noncompliant. He was fighting a disease no one bothered to look for.
Still, he climbed the corporate ladder in the automotive coatings industry. He earned promotions. He delivered results. But his body was breaking. And behind every workday win, there was a night spent battling exhaustion, shame, and the creeping belief that maybe it really was his fault.
A Systemic Breakdown
By 2013, his body sent a blunt memo: collapse. Dean landed in the ICU with diabetic ketoacidosis. An endocrinologist was consulted, but not to solve the underlying mystery—just the emergency. Despite glaring signs—signs his family had documented in detail—no one ordered a test for Cushing's. Even after introducing a second endocrinologist, even after infections ravaged his system, even as his skin tore in a workplace fall, nothing changed.
It wasn't until 2019 that a single primary care physician broke the inertia. He reviewed his whole history, acknowledged the pattern, and ordered the cortisol tests that would finally unveil the truth: Cushing's disease. Twenty-three years after it all began.
Recovery Is Not Linear
The tumor was removed in 2020. But there was no triumphant return, no swift rebound. Recovery was glacial. Dean's body, once flooded with cortisol, was suddenly starved of it. Cortisol had to be administered by medication. Energy flatlined. Nights stretched long and restless. Then came the back pain, unrelenting and tied to years of untreated structural damage.
"There wasn't a morning I woke up feeling better," Dean says. "There were just mornings I woke up and decided to try again."
Sound familiar? Founders know this rhythm. Recovery isn't always exponential growth; it's the grind. The grit. The decision to show up despite the metrics still being red.
Turning Pain into Platform
This book, Surviving Cushing's Disease: A Young Man's Journey, is Dean's first act of advocacy. Not a TED Talk. Not a foundation. Just this: a deeply personal, unapologetic account of what it means to be invisible in a system designed to treat averages, not anomalies.
In its pages, the symptoms of Cushing's—unexplained weight gain, thinning skin, recurrent infections—are given shape and language. Not to diagnose, but to awaken awareness. Dean's story is not a callout. It's a call forward.
Startups, Survivors, and Second Opinions
Entrepreneurs can draw from Dean's journey as much as patients can:
Follow the fringe data : When something feels off—even if others don't see it—pursue it.
: When something feels off—even if others don't see it—pursue it. Pressure test the system : Experts are invaluable. But they are not infallible.
: Experts are invaluable. But they are not infallible. Leverage the pain: Your hardest chapters may become your most powerful pages.
Because sometimes, the most resilient visionaries don't wear lanyards or give keynotes. They survive in silence for years. Then one day, they write.
And someone else learns how to speak up.
Click here for Amazon
Website: https://tales2btold.com/
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Major Health Insurers Slash Prior Authorization Requirements, Transforming the PA Technology Landscape
Major Health Insurers Slash Prior Authorization Requirements, Transforming the PA Technology Landscape

Yahoo

time3 hours ago

  • Yahoo

Major Health Insurers Slash Prior Authorization Requirements, Transforming the PA Technology Landscape

Black Book Research identifies Cohere Health, Innovaccer, and Waystar among leading vendors rapidly adapting to new industry rules. NEW YORK CITY, NY / / July 26, 2025 / U.S. healthcare is undergoing a pivotal shift as major insurers-led by UnitedHealthcare and Humana-begin to significantly reduce or eliminate prior authorization (PA) requirements for hundreds of routine procedures. Accelerated by federal policy, provider frustration, and consumer demands for timely access to care, these sweeping changes signal a new era in PA technology and operations, according to a July 2025 flash survey conducted by Black Book Research. Industry Drivers: Regulatory Action Meets Provider and Consumer Pressure Insurers covering over 250 million Americans have committed to streamlining or removing PA burdens by the end of 2026. This is partly driven by the Centers for Medicare & Medicaid Services (CMS), which is launching a pilot program in six states in January 2026 requiring faster, more transparent prior authorizations for select Medicare services. CMS has also announced national response time standards for Medicare Advantage plans, further intensifying the need for automation and interoperability in PA processes. Key Survey Insights from the Field Black Book Research's flash survey compiled viewpoints from: 24 IT leaders representing the top 10 PA vendors; 108 managed care and health plan IT and operational decision-makers; 142 healthcare providers and administrative leaders; and 100 healthcare consumers with recent PA experiences. Notable Findings: 84% of managed care executives support reducing PA requirements 96% of healthcare providers report improved workflows and lower administrative burdens 99% of consumers favor eliminating PA for routine care; 83% say they've experienced harmful care delays 67% of health plans expect to reevaluate or end contracts with existing PA vendors by 2026 Additional Observations: 90% of providers foresee broad adoption of interoperable PA tools by 2027 94% of payers plan substantial investment in AI-based PA platforms 100% of consumers prefer providers with automated and transparent PA processes 96% of PA vendor executives acknowledge their current solutions require modernization within two years __________ Vendors Rapidly Adapting and Leading the Innovation Curve: Client Top KPI Scores Black Book highlights the top-performing vendors already making critical advancements to align with industry shifts: Cohere Health - Excels in AI-based automation, payer-provider integration, and CMS-aligned interoperability Innovaccer - Offers strong EHR integration and regulatory compliance dashboards for PA workflows Waystar - Enhancing its Auth Accelerate platform for real-time eligibility checks and exception handling ScribeRunner - Developing dynamic auto-approval rulesets and real-time tracking modules CoverMyMeds - Expanding AI-powered real-time authorizations for both pharmacy and medical benefits Change Healthcare - Transitioning legacy infrastructure with modular FHIR APIs for automated decision-making Availity - Driving advanced API adoption and digital submission channels PriorAuthNow (Rhyme) - Connecting providers and payers through real-time electronic submission with limited manual effort Black Book's Q1-Q2 client satisfaction rankings show these vendors excelled across 18 qualitative KPIs for PA technology. Cohere Health earned the highest overall honors, with MCG Health, eviCore Healthcare, Agadia, Infinx, and Availity also receiving good marks. Onyx led in FHIR-based PA platform innovation. Detailed competitive intelligence reports are available in the Black Book research store. __________ Vendors Facing Existential Threats in the New Era Not all companies are poised for success. Several previously top-rated PA vendors now face considerable risk due to outdated systems and slow adaptability: eviCore Healthcare - Still dependent on manual review processes, with limited AI capabilities HealthHelp (WNS) - Lagging behind in interoperability and modern payer integration PriorAuthNow (Rhyme) - Despite innovation efforts, struggles with scalable real-time API integration threaten its long-term viability _________ Looking Ahead: A Positive Outlook for Adaptive Vendors While legacy vendors must evolve rapidly or risk market exit, the broader outlook for PA tech is optimistic. Companies investing in automated, intelligent, and interoperable systems are well-positioned to thrive. "The future of prior authorization is transparent, automated, and fully integrated into clinical workflows," said Doug Brown, Founder of Black Book Research. "Vendors delivering real-time, AI-powered solutions will define the next generation of care access efficiency for providers, payers, and patients alike." About Black Book Research Black Book Research is a leading healthcare IT research firm known for its independent, vendor-agnostic approach. Over the past 15 years, Black Book has collected over 3 million survey responses from nearly 500,000 healthcare professionals. The firm's flash surveys and long-form evaluations provide real-time, unbiased insights that support strategic decision-making across the healthcare ecosystem. Visit or contact research@ for full survey results and vendor-specific performance details. Contact Information Press Office research@ SOURCE: Black Book Research View the original press release on ACCESS Newswire Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

This Small Town Greek Doctor on How He Uses AI: ‘'Without AI, Q Fever Might Not Have Been on Our List'
This Small Town Greek Doctor on How He Uses AI: ‘'Without AI, Q Fever Might Not Have Been on Our List'

Gizmodo

time4 hours ago

  • Gizmodo

This Small Town Greek Doctor on How He Uses AI: ‘'Without AI, Q Fever Might Not Have Been on Our List'

Ioannina, a lakeside town in northern Greece surrounded by mountains, is not the kind of place you expect to find cutting-edge artificial intelligence quietly reshaping medicine. Yet, inside its main public hospital, Dr. Tzimas is doing just that. Dr. Tzimas is quietly reshaping how medicine is practiced. From spotting rare diseases like Q fever to managing conflicts among junior doctors, Dr. Tzimas has woven AI into the rhythm of daily medical life. However, he believes that AI will not be able to replace the essential human interactions that are at the heart of his work. 'You have to listen to lung sounds, palpate the abdomen, look patients into their eyes,' he says. 'AI can't feel pain responses or smell signs of illness.' Dr. Tzimas is the director of the Internal Medicine Department at General Hospital of Ioannina 'G. Hatzikosta.' This interview is part of our series How Do You Use AI, where we ask people one simple question: How do you use AI? No TED Talk nonsense, just real life. Episode 3: Dr. Thomas Tzimas—AI Pragmatist. Gizmodo: How does AI fit into your daily medical practice? Dr. Tzimas: AI acts as an assistant that helps us work faster and more reliably. We feed it solid data, review the output, and proceed if it's okay. This is particularly helpful when we need to respond to insurance companies about a patient's situation or send emails to family physicians. Gizmodo: Can you give a specific example of how AI assists with patient care? Dr. Tzimas: One major area is drug interactions. There are extensive tables of drug interactions, but they're difficult to access quickly when you're with a patient. AI systems can provide this information very easily and without mistakes. It also helps with adjusting dosages for patients with conditions like renal insufficiency or hepatic failure, where normal doses might be harmful. Gizmodo: Are you concerned about AI 'hallucinations' or inaccuracies in the medical field? Dr. Tzimas: An experienced clinician can spot hallucinations right away. If you prompt the AI with very strict protocols, they do not hallucinate. The 'temperature' setting of AI models is crucial; for the medical field, it needs to be set to 0.3, which makes them very strict and prevents them from fantasizing or hallucinating. Normal AI systems often have a temperature of 1, which leads to a lot of fantasizing and hallucinating. Gizmodo: Do you use AI for personal matters? Dr. Tzimas: I use AI for almost all my emails, especially within the communication platform among doctors. I use a 'negotiator GPT' prompt that makes answers very diplomatic. This is particularly useful when there's a conflict among junior doctors, as I have to maintain integrity and prevent conflicts while still being strict. It helps me reply in a way that smooths over potential issues, like an accomplished diplomat would. Gizmodo: Interesting… Dr. Tzimas: I also use AI to create teaching materials very quickly. For instance, I can take a complex clinical case from a journal like the New England Journal of Medicine and ask the system to create multiple-choice questions from it. I then present these questions to the doctors, and I can see who answers correctly or incorrectly. The next day, I provided the correct answer. AI also helps me summarize large articles and complex medical cases from journals for easier discussion. This has freed up a lot of my time. Gizmodo: Does AI assist with diagnosis? Dr. Tzimas: AI tools are really capable for differential diagnosis. If a patient presents with a symptom like fever, it could be a thousand things. With AI, we can narrow down the possibilities to less than 10, and then through clinical examination, imaging, and consultations, we narrow it down to one. The system can even remind you of really rare conditions that might be happening to your patient. Gizmodo: When was the last time AI helped you in a case? Dr. Tzimas: A few hours ago, we completed a difficult case. One patient, a labor worker, had inhaled a lot of dust in a sheep and goat stable and came in with a fever. We used AI to consider what diseases could be contracted from dust in such a stable. One of the highly-ranked differential diagnoses was Q fever, which is very rare. We sent a blood sample to Athens to exclude it. Although it came back negative and the final diagnosis was unrelated, the AI system identified Q fever as a potential possibility, which opened our horizons. Without AI, Q fever might not have even on our list. Gizmodo: Do your patients use AI themselves? Dr. Tzimas: Yes, some patients now use AI, similar to how they used to Google their symptoms. They might come in saying, 'This is what ChatGPT said,' and we have to respond to that. As AI spreads, people with health questions will use it to get analyses of their symptoms. Our job as doctors remains the same: to professionally answer questions and provide credible answers and solutions. This means doctors also need to use AI for support, paperwork, and even creating dietary plans for patients. Gizomo: Does AI replace the need for administrative staff, like a personal assistant? Dr. Tzimas: It reduces the need. For example, my previous boss would write notes on paper for his assistant to type. Now, I dictate notes on my iPhone, copy-paste them into an AI system, and it creates a nice email. Also, I can take pictures of paper documents, and AI can transcribe them into a digital form, saving tons of time and creating digital archives. Gizmodo: Are you worried about AI replacing you? Dr. Tzimas: No, not at all. My job involves experience that AI cannot yet replicate. I need to listen to lung, heart, and bowel sounds, palpate patients, and inspect them. While AI might analyze a digital photograph of a skin lesion, it cannot palpate a patient and feel the intensity of pain or guarding. These are qualities that rely on a doctor's senses, like smelling a patient's breath to detect diabetic ketoacidosis. Human interaction, like looking a patient in the eyes, observing their demeanor, and assessing their hygiene, provides crucial information that AI cannot easily replace. AI helps save time, but it needs an experienced physician to input those essential details. Gizmodo: How does AI affect your work-life balance? Dr. Tzimas: It saves time. Preparing teaching material used to take me hours; now I just spend an hour or a couple of hours and I'm ready. So I have more time for my personal life.

US Health Officials, Tech Executives to Launch Data-Sharing Plan
US Health Officials, Tech Executives to Launch Data-Sharing Plan

Bloomberg

time4 hours ago

  • Bloomberg

US Health Officials, Tech Executives to Launch Data-Sharing Plan

Top Trump administration health officials are expected to bring tech companies to the White House this week to roll out a plan to encourage more seamless sharing of health-care data, according to people familiar with the matter. Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz are expected to host executives at an event on Wednesday, said the people, who did not provide names of the attendees and asked not to be named because the details haven't been made public.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store